Renalogic News

Renalogic Announces Record Growth in 2022 – CKD Management Company Continues to be Category Leader

Media Release

CHICAGO, IL – February 14, 2023 – Renalogic, the leading company helping employers and self-funded health plans fight the human and financial costs of chronic kidney disease (CKD) and end-stage renal disease (ESRD), announced record growth in 2022.

In 2022, Renalogic added more than 75 new client plans which support more than 150,000 members. These new clients range in size from a plan with a few dozen plan members up to a Fortune 500 company with 50,000 members. All types of self-funded plans and industries were represented by these new clients, including Taft-Hartley plans, municipal plans, and employer plans in retail, transportation, construction, leisure, and health care industries. Through these expanded relationships, Renalogic now supports the financial and clinical health of nearly 600,000 members in all 50 states.

The company also expanded its relationship with channel partners, welcoming some of the nation’s leading third-party administrators and benefit brokerages and consulting firms.

During the year, Renalogic’s cost-saving solution saved clients more than $50 million and was certified by the Validation Institute, as being a major cost-saver for self-funded plans.

Among the impacts of the company’s care management services was the company’s ability to intervene early to prevent the progression of CKD. For example, Renalogic was twice as effective as the general commercial market in forestalling the progression of members with CKD stage 2 progressing to CKD stage 4. Renalogic was similarly impactful in helping late-stage CKD sufferers. The company was able to prevent 86% of members who entered Renalogic’s program at CKD stage 5 from progressing to dialysis.

“2022 was a great year for our clients and for our company,” said Kevin Weinstein, CEO of Renalogic. “We helped thousands of members via our ImpactCare and ImpactAdvocate care management services and saved our clients and their members millions of dollars through ImpactProtect, our category-leading cost containment service.”

The company also announced that it has fully migrated its technology to a new cloud partner and formally relocated its headquarters to Chicago.

For more information about Renalogic, visit www.renalogic.com.

About Renalogic

Founded in 2002, Renalogic helps self-funded plans of all sizes and their U.S-based health plan members reduce the human and financial costs of chronic kidney disease (CKD) and dialysis treatment. We help plans manage dialysis claims costs and work to prevent members from progressing to dialysis. Through our cost containment and population health management solutions, Renalogic is 230% better than commercial plans at identifying undiagnosed CKD, 86% effective at preventing members from kidney failure and delivers 84.5% average savings off contracted rates with our claims repricing. We’ve saved our clients over $780,000,000 and helped stop CKD from progressing for thousands of members.